BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22480936)

  • 1. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
    Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT
    Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional and novel approaches to flavivirus vaccines.
    Pugachev KV; Guirakhoo F; Trent DW; Monath TP
    Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in flavivirus vaccines with special attention to yellow fever.
    Pugachev KV; Guirakhoo F; Monath TP
    Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Attenuating Mutations: Tools for a New Vaccine Design against Flaviviruses.
    Khou C; Pardigon N
    Intervirology; 2017; 60(1-2):8-18. PubMed ID: 28869941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination.
    Kaaijk P; Luytjes W
    Hum Vaccin Immunother; 2018 Feb; 14(2):337-344. PubMed ID: 29053401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
    Widman DG; Frolov I; Mason PW
    Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mimicking live flavivirus immunization with a noninfectious RNA vaccine.
    Kofler RM; Aberle JH; Aberle SW; Allison SL; Heinz FX; Mandl CW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1951-6. PubMed ID: 14769933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
    Eckels KH; Putnak R
    Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune evasion strategies of flaviviruses.
    Ye J; Zhu B; Fu ZF; Chen H; Cao S
    Vaccine; 2013 Jan; 31(3):461-71. PubMed ID: 23153447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of flavivirus vaccines.
    Barrett AD
    Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines for flaviviruses.
    Putnak R; Porter K; Schmaljohn C
    Adv Virus Res; 2003; 61():445-68. PubMed ID: 14714440
    [No Abstract]   [Full Text] [Related]  

  • 20. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.
    Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET
    An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.